SCHEMBL30784502

SCHEMBL30784502

Cn1c(N2CCOCC2)nc2c(Br)cc(Cl)cc2c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ STAT6 P42226 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ DRD2 P14416 1/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ BRD4 O60885 1/20 0.41
▸ BRD2 P25440 1/20 0.41
▸ BRD3 Q15059 1/20 0.41
▸ CREBBP Q92793 1/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ DPP4 P27487 1/20 0.39
▸ PRKDC P78527 2/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ CCNC P24863 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30784051 0.86 HTT (0.43) SMN1; SMN2LMNASTAT6HTTDRD2
SCHEMBL30784241 0.86 HTT (0.43) SMN1; SMN2LMNASTAT6HTTDRD2
SCHEMBL30784114 0.85 HTT (0.42) SMN1; SMN2LMNASTAT6HTTDRD2
SCHEMBL30784281 0.84 DPP4 (0.45) SMN1; SMN2LMNASTAT6HTTDRD2
SCHEMBL30783708 0.84 HTT (0.41) SMN1; SMN2LMNASTAT6HTTDRD2
SCHEMBL25359600 0.83 PTPN11 (0.39) —
SCHEMBL30783877 0.83 HTT (0.41) SMN1; SMN2LMNASTAT6HTTDRD2
SCHEMBL30495052 0.83 PTPN11 (0.39) —
SCHEMBL30784048 0.82 CRHR1 (0.41) SMN1; SMN2LMNASTAT6HTTDRD2
SCHEMBL30784290 0.82 HTT (0.40) SMN1; SMN2LMNASTAT6HTTDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback